Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi.
about
Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: data from an HIV cohort study in India.A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.Multi-level factors affecting entry into and engagement in the HIV continuum of care in Iringa, TanzaniaRetention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literatureFactors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.Antiretroviral adherence interventions in Southern Africa: implications for using HIV treatments for prevention.High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.Depression and Engagement in Care Among Newly Diagnosed HIV-Infected Adults in Johannesburg, South Africa.Barriers to antiretroviral treatment initiation in rural KwaZulu-Natal, South Africa.Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa.Integrating family planning services into HIV care: use of a point-of-care electronic medical record system in Lilongwe, Malawi.Predictors of timely linkage-to-ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case-control study.
P2860
Q30704115-D88DC62B-2FC3-4DFF-86A3-65BFD2CFFE5AQ33626374-ED958ECE-F3B1-4A71-A593-80B42E6AA603Q33883748-9CA58485-3C17-4A1B-8007-CCCA1F6161D4Q34066025-ED7CB7BD-178D-4157-BCD8-158CCACAF8B5Q35778800-6464A28A-7846-41E9-BA0D-7B9908C39800Q37395475-85A724FA-806A-4346-AEAE-63708670BED8Q38175876-455252F7-BFD1-45ED-AF69-5C40D8EF4CDAQ38597819-45D14E90-6D63-4E45-9086-1C9E12FD9E23Q40649510-05A92F36-DC4C-4088-AC4C-48E1E656DE5DQ46139842-6556D7B8-447C-47B9-9AC4-1419611DB945Q46570650-E8E0800A-565B-49A6-8E5D-9EFE7C9D4089Q47100222-2528C513-811E-44D8-B283-8AE7A5885D5BQ47292480-0D6112AA-6908-4392-B45A-83A888DDA27C
P2860
Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@ast
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@en
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@nl
type
label
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@ast
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@en
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@nl
prefLabel
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@ast
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@en
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@nl
P2093
P2860
P1433
P1476
Who starts? Factors associated ...... V clinics in Lilongwe, Malawi.
@en
P2093
Derek Johnson
Hannock Tweya
Mina Hosseinipour
P2860
P304
P356
10.1371/JOURNAL.PONE.0050871
P407
P577
2012-11-30T00:00:00Z